Maravai Lifesciences Holdings Income Statement (2020-2025) | MRVI

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 50.98M46.91M87.86M98.35M148.21M217.78M204.81M228.44M244.29M242.73M191.26M204.71M79.03M68.91M66.86M74.14M64.18M69.42M69.03M56.56M46.85M47.40M41.63M
Cost of Revenue 15.30M21.20M19.76M23.39M31.39M37.81M32.22M39.14M40.03M37.50M38.18M53.25M33.68M43.27M36.69M35.11M38.34M38.58M36.79M37.17M39.12M39.63M35.98M
Gross Profit 35.68M25.71M68.10M74.96M116.82M179.96M172.59M189.31M204.26M205.24M153.09M151.46M45.35M25.64M30.18M39.03M25.84M30.84M32.23M19.39M7.72M7.77M5.66M
Operating items
Research & Development 3.74M1.60M1.87M2.09M2.16M1.93M1.95M9.18M3.69M4.27M5.39M5.01M4.14M4.19M4.35M4.59M5.03M4.92M4.70M4.56M4.89M4.88M3.84M
Selling, General & Administrative 16.13M15.99M20.51M41.62M23.47M24.50M26.51M25.58M33.20M28.06M30.80M37.20M38.67M35.38M38.86M38.48M40.88M40.56M39.09M41.24M39.56M38.58M35.40M
Restructuring Costs 6.47M-1.21M-0.00M-0.00M0.01M7.39M
Other Operating Expenses -3.71M21.20M19.76M23.39M31.39M37.81M11.25M39.14M40.03M29.70M38.18M53.25M33.68M40.96M39.07M31.75M38.34M37.39M154.06M162.16M51.56M70.22M0.06M
Operating Expenses 16.16M38.78M42.14M67.11M57.02M64.24M49.43M73.90M76.93M62.03M74.36M95.47M76.49M80.53M82.28M81.29M83.04M82.86M197.85M207.97M96.01M113.67M46.69M
Operating Income 34.82M8.12M45.72M31.25M91.19M153.53M155.38M154.54M167.37M180.70M116.90M109.25M2.53M-11.61M-15.42M-7.15M-18.86M-13.44M-165.61M-37.70M-49.16M-66.28M-41.03M
EBIT 34.82M8.12M45.72M31.25M91.19M153.53M155.38M154.54M167.37M180.70M116.90M109.25M2.53M-11.61M-15.42M-7.15M-18.86M-13.44M-165.61M-37.70M-49.16M-66.28M-41.03M
Non-operating items
Interest & Investment Income 2.34M6.04M6.79M7.43M7.46M7.21M7.09M7.07M6.04M3.23M3.03M2.80M
Other Non Operating Income 0.08M0.02M0.03M-7.72M0.00M-0.00M0.08M0.20M-0.21M-1.27M-0.00M0.91M0.17M-1.62M0.07M0.05M0.11M-2.56M0.07M-0.80M0.02M-4.06M-0.07M
Non Operating Income 0.08M0.03M-0.01M0.00M-0.00M0.08M0.20M0.01M-1.27M-0.00M0.91M0.17M-1.62M0.07M0.05M0.11M-2.56M0.07M0.04M0.02M-4.06M-0.07M
Net income details
EBT 27.51M0.68M38.66M14.84M89.17M145.88M151.02M144.69M166.84M174.99M113.76M95.88M-4.52M-13.36M-20.56M656.19M-22.41M-20.86M-172.14M-46.07M-52.69M-74.12M-45.15M
Tax Provisions 3.63M-0.77M-0.36M0.37M13.71M11.39M18.84M17.58M19.98M18.27M14.11M8.45M-3.17M-1.42M-5.46M766.17M0.27M-2.44M0.31M-0.01M0.16M-4.29M-0.09M
Profit After Tax 23.88M1.44M39.02M11.43M75.47M134.50M132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M
Income from Non-Controlling Interests 0.49M0.02M0.07M-10.74M52.36M85.35M78.22M71.28M80.00M85.48M55.18M49.80M-1.28M-5.40M-8.64M-4.02M-10.60M-8.63M-75.38M-20.16M-22.91M-30.25M-19.50M
Income from Continuing Operations 23.88M1.44M39.02M14.47M75.47M134.50M132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M
Consolidated Net Income 23.88M1.44M39.02M14.47M75.47M134.50M132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M
Income towards Parent Company 23.88M1.44M39.02M14.47M75.47M134.50M132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M
Net Income towards Common Stockholders 23.88M1.44M39.02M14.47M75.47M134.50M132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M
Additional items
EPS (Basic) 0.090.010.127.220.240.440.460.430.510.540.340.28-0.01-0.05-0.05-0.80-0.09-0.07-0.68-0.18-0.21-0.27-0.18
EPS (Weighted Average and Diluted) 0.090.010.122.150.240.440.440.430.500.530.340.30-0.01-0.05-0.05-0.80-0.09-0.07-0.68-0.18-0.21-0.27-0.18
Shares Outstanding (Weighted Average) 257.84M257.84M257.84M257.84M257.66M257.66M257.70M255.16M255.16M255.21M255.21M250.88M250.88M250.98M251.02M251.40M251.40M251.92M252.24M252.53M254.34M254.66M255.36M
Shares Outstanding (Diluted Average) 253.92M253.92M253.92M28.91M96.67M257.69M258.03M257.80M255.29M255.36M255.32M255.32M131.74M131.86M131.93M131.92M132.33M135.84M141.56M137.91M143.43M144.24M144.68M
EBITDA 34.82M8.12M45.72M31.25M91.19M153.53M155.38M154.54M167.37M180.70M116.90M109.25M2.53M-11.61M-15.42M-7.15M-18.86M-13.44M-165.61M-37.70M-49.16M-66.28M-41.03M
Interest Expenses 7.38M7.46M7.09M8.81M7.90M7.65M7.68M7.02M2.66M4.43M3.14M10.18M11.83M7.02M11.64M15.40M10.86M11.94M13.63M11.26M6.78M6.82M6.84M
Tax Rate 13.21%2.49%15.37%7.80%12.48%12.15%11.98%10.44%12.40%8.81%70.20%10.63%26.56%11.68%0.02%5.78%0.20%